DK1093818T3 - Pulverformigt præparat til mukosal indgivelse indeholdende polymert lægemiddel - Google Patents

Pulverformigt præparat til mukosal indgivelse indeholdende polymert lægemiddel

Info

Publication number
DK1093818T3
DK1093818T3 DK99926887T DK99926887T DK1093818T3 DK 1093818 T3 DK1093818 T3 DK 1093818T3 DK 99926887 T DK99926887 T DK 99926887T DK 99926887 T DK99926887 T DK 99926887T DK 1093818 T3 DK1093818 T3 DK 1093818T3
Authority
DK
Denmark
Prior art keywords
containing polymeric
mucosal administration
administration containing
polymeric drug
powdered preparation
Prior art date
Application number
DK99926887T
Other languages
Danish (da)
English (en)
Inventor
Hideaki Nomura
Yosuke Ueki
Original Assignee
Kirin Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26422571&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1093818(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kirin Amgen Inc filed Critical Kirin Amgen Inc
Application granted granted Critical
Publication of DK1093818T3 publication Critical patent/DK1093818T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99926887T 1998-07-08 1999-07-01 Pulverformigt præparat til mukosal indgivelse indeholdende polymert lægemiddel DK1093818T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19272298 1998-07-08
JP8154999 1999-03-25

Publications (1)

Publication Number Publication Date
DK1093818T3 true DK1093818T3 (da) 2006-07-17

Family

ID=26422571

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99926887T DK1093818T3 (da) 1998-07-08 1999-07-01 Pulverformigt præparat til mukosal indgivelse indeholdende polymert lægemiddel

Country Status (27)

Country Link
US (2) US20050271728A1 (cs)
EP (2) EP1637154A3 (cs)
JP (1) JP3422775B2 (cs)
KR (1) KR100606857B1 (cs)
CN (1) CN1180839C (cs)
AT (1) ATE320816T1 (cs)
AU (1) AU764331B2 (cs)
BG (1) BG65040B1 (cs)
BR (1) BR9911890A (cs)
CA (1) CA2332559C (cs)
CZ (1) CZ300931B6 (cs)
DE (1) DE69930509T2 (cs)
DK (1) DK1093818T3 (cs)
EA (1) EA003672B1 (cs)
ES (1) ES2260916T3 (cs)
HK (1) HK1039283B (cs)
HU (1) HUP0103396A3 (cs)
IL (2) IL140669A0 (cs)
MX (1) MXPA01000032A (cs)
NO (1) NO20010042L (cs)
NZ (1) NZ509710A (cs)
PL (1) PL193805B1 (cs)
PT (1) PT1093818E (cs)
RS (1) RS49890B (cs)
SK (1) SK262001A3 (cs)
TW (1) TWI225411B (cs)
WO (1) WO2000002574A1 (cs)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2403962C (en) 2000-03-31 2009-12-15 Kirin Beer Kabushiki Kaisha Powdery preparation for transmucosal administration comprising a medicine of high molecular weight and exhibiting an improved storage stability
KR100863146B1 (ko) 2000-07-17 2008-10-14 아스텔라스세이야쿠 가부시키가이샤 경구 흡수 개선 의약 조성물
US7923025B2 (en) 2002-01-16 2011-04-12 Astellas Pharma Inc. Pharmaceutical composition for oral use with improved absorption
WO2004064811A1 (en) * 2003-01-24 2004-08-05 Magle Holding Ab A composition material for transmucosal delivery
SE0302947D0 (sv) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
GB0315632D0 (en) * 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
US8202550B2 (en) 2004-10-11 2012-06-19 Nasaleze Ppm Limited Compositions for intranasal administration
EP1824450B1 (en) * 2004-10-11 2012-11-14 Nasaleze Patents Limited Compositions for intranasal administration
JP5103748B2 (ja) * 2005-02-16 2012-12-19 東レ株式会社 医薬組成物
CU23317A1 (es) * 2005-07-22 2008-10-22 Ct De Investigacia N Y Desarro Formulaciones nasales de eporh con bajo contenido de ã cido siã lico para el tratamiento de enfermedades del sistema nervioso central
WO2008127833A2 (en) * 2007-03-19 2008-10-23 University Of Florida Research Foundation, Inc. Enhancing efficacy of vaccines administered via the respiratory tract
JP5171102B2 (ja) * 2007-05-02 2013-03-27 東亜薬品株式会社 経鼻吸収用睡眠導入剤
WO2010037142A1 (en) * 2008-09-29 2010-04-01 The Corporation Of Mercer University Nanospheres encapsulating bioactive material and method for formulation of nanospheres
US10004790B2 (en) 2008-09-29 2018-06-26 The Corporation Of Mercer University Nanospheres encapsulating bioactive material and method for formulation of nanospheres
US11524058B2 (en) 2008-09-29 2022-12-13 The Corporation Of Mercer University Oral dissolving films containing microencapsulated vaccines and methods of making same
US10463608B2 (en) 2008-09-29 2019-11-05 The Corporation Of Mercer University Microneedle-based transdermal delivery system and method of making same
JP5804453B2 (ja) * 2009-05-14 2015-11-04 国立大学法人 東京大学 結晶性ポリオール微粒子及びその調製方法
PL4104848T3 (pl) 2009-06-18 2024-03-25 Acerus Pharmaceuticals USA, LLC Bezpieczne podawanie desmopresyny
US9084727B2 (en) * 2011-05-10 2015-07-21 Bend Research, Inc. Methods and compositions for maintaining active agents in intra-articular spaces
GB201109311D0 (en) * 2011-06-03 2011-07-20 Avimir Ip Ltd Method and computer program for providing authentication to control access to a computer system
EP2833914B1 (en) * 2012-04-04 2019-01-16 Vaxform LLC Adjuvant system for oral vaccine administration
CN104208029B (zh) * 2013-05-30 2017-06-06 上海医药工业研究院 一种鼻用疫苗组合物粉体制剂及其制备方法
US11628208B2 (en) 2015-10-05 2023-04-18 The Corporation Of Mercer University System and method for microneedle delivery of microencapsulated vaccine and bioactive proteins
WO2017062463A1 (en) 2015-10-05 2017-04-13 The Corporation Of Mercer University Nanospheres encapsulating bioactive material and method for formulation of nanospheres
EP3459529A1 (en) * 2017-09-20 2019-03-27 Tillotts Pharma Ag Preparation of sustained release solid dosage forms comprising antibodies by spray drying
CN112601541B (zh) * 2018-06-22 2024-12-27 比欧拉利克斯有限公司 口服给药的生物聚合物制剂
PL3962455T3 (pl) * 2020-05-18 2023-01-16 Orexo Ab Nowa kompozycja farmaceutyczna do dostarczania leku
GB202117016D0 (en) 2021-11-25 2022-01-12 Orexo Ab New pharmaceutical device
AU2022395920A1 (en) 2021-11-25 2024-05-30 Orexo Ab Pharmaceutical composition comprising adrenaline
EP4226912A1 (en) * 2022-02-09 2023-08-16 Catalya A polymer to increase the bioavailability of a pharmaceutical compound
WO2025005804A1 (en) * 2023-06-28 2025-01-02 Leyden Laboratories B.V. Mucoadhesive formulation

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US807552A (en) * 1904-07-30 1905-12-19 John Guiry Dumping-scow.
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
JP2577743B2 (ja) * 1986-07-18 1997-02-05 中外製薬株式会社 安定な顆粒球コロニ−刺激因子含有製剤
US4760093A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4721020A (en) * 1986-10-27 1988-01-26 Stumpf Gary B Ski sharpening guide and method of employing same
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
GB8920381D0 (en) * 1989-09-08 1989-10-25 Greater Glasgow Health Board Treatment of insulin-resistant diabetes
JP2841714B2 (ja) * 1990-05-22 1998-12-24 大正製薬株式会社 持効性点鼻剤
JP3283288B2 (ja) * 1991-03-08 2002-05-20 電気化学工業株式会社 生理活性ペプチド製剤
AU676315B2 (en) * 1993-06-30 1997-03-06 Takeda Chemical Industries Ltd. Stabilized solid pharmaceutical preparation and method of producing the same
JPH07118170A (ja) * 1993-10-19 1995-05-09 Dot:Kk 経鼻吸収薬物用キャリヤ、生理活性ペプチド組成物およびその製造法
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US5783178A (en) * 1994-11-18 1998-07-21 Supratek Pharma. Inc. Polymer linked biological agents
JPH08198772A (ja) * 1994-11-25 1996-08-06 Kirin Brewery Co Ltd 顆粒球コロニー刺激因子含有粉末経鼻投与製剤
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
US6391338B1 (en) * 1995-09-07 2002-05-21 Biovail Technologies Ltd. System for rendering substantially non-dissoluble bio-affecting agents bio-available
JP3197221B2 (ja) * 1996-02-27 2001-08-13 帝人株式会社 吸収性が改善された粉末状経鼻投与組成物
JP3197222B2 (ja) * 1996-02-28 2001-08-13 帝人株式会社 粉末状経鼻投与組成物
JP3770666B2 (ja) * 1996-09-20 2006-04-26 株式会社ティ・ティ・エス技術研究所 経粘膜吸収製剤用組成物
US5889051A (en) * 1997-07-15 1999-03-30 Development Center For Biotechnology Stabilization of prostaglandin drug
EP1027036A2 (en) * 1997-10-03 2000-08-16 ELAN CORPORATION, Plc Taste masked formulations
US6669951B2 (en) * 1999-08-24 2003-12-30 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into epithelial tissues
US8075520B2 (en) * 2006-04-06 2011-12-13 Reznik Alan M Arthroscopic fluid control device and method for controlling fluid flow in arthroscopic procedures

Also Published As

Publication number Publication date
WO2000002574A1 (fr) 2000-01-20
JP3422775B2 (ja) 2003-06-30
US20090028814A1 (en) 2009-01-29
ES2260916T3 (es) 2006-11-01
DE69930509T2 (de) 2006-11-30
EP1093818B9 (en) 2007-10-17
NO20010042D0 (no) 2001-01-04
BG105169A (en) 2001-12-29
AU4395899A (en) 2000-02-01
EA003672B1 (ru) 2003-08-28
EP1637154A3 (en) 2007-08-15
EP1093818A4 (en) 2004-03-31
CA2332559A1 (en) 2000-01-20
DE69930509D1 (de) 2006-05-11
BG65040B1 (bg) 2007-01-31
IL140669A (en) 2007-06-03
CA2332559C (en) 2008-01-15
BR9911890A (pt) 2001-03-27
NO20010042L (no) 2001-03-05
EA200100118A1 (ru) 2001-08-27
KR20010053302A (ko) 2001-06-25
NZ509710A (en) 2003-10-31
EP1093818B1 (en) 2006-03-22
US20050271728A1 (en) 2005-12-08
CZ20016A3 (en) 2001-05-16
HK1039283A1 (en) 2002-04-19
PL345456A1 (en) 2001-12-17
HUP0103396A3 (en) 2002-05-28
MXPA01000032A (es) 2002-10-17
HK1039283B (zh) 2005-04-29
CZ300931B6 (cs) 2009-09-16
PL193805B1 (pl) 2007-03-30
TWI225411B (en) 2004-12-21
RS49890B (sr) 2008-08-07
IL140669A0 (en) 2002-02-10
EP1637154A2 (en) 2006-03-22
HUP0103396A2 (hu) 2002-02-28
ATE320816T1 (de) 2006-04-15
AU764331B2 (en) 2003-08-14
EP1093818A1 (en) 2001-04-25
CN1315864A (zh) 2001-10-03
YU1101A (sh) 2003-08-29
CN1180839C (zh) 2004-12-22
KR100606857B1 (ko) 2006-08-01
PT1093818E (pt) 2006-07-31
SK262001A3 (en) 2001-09-11

Similar Documents

Publication Publication Date Title
DK1093818T3 (da) Pulverformigt præparat til mukosal indgivelse indeholdende polymert lægemiddel
GR3003420T3 (en) Buccal drug dosage form
ATE250593T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
AU1079701A (en) Oral transmucosal drug dosage using solid solution
HUP9904174A2 (hu) Bőrön át történő adagoláshoz szánt gyógyszerkészítmények
CA2116563A1 (en) Dry gel pharmaceutical composition
KR101066763B1 (ko) 온도 반응성 전달계
DK1417959T3 (da) Tablet til buccal, sublingual eller gingival administration omfattende et brusende reaktant-par
ATE188471T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
MX9804008A (es) Formulaciones farmaceuticas.
DE60211464D1 (de) Pharmazeutische formulierungen mit kontrollierter wirkstoff-freigabe enthaltend milchsäure-polymer, sowie deren herstellung
DE69836207D1 (de) Orale pharmazeutische zusammensetzungen mit reduzierter bitterkeit durch geschmacksmaskiermittel
IT1275816B1 (it) Composizioni farmaceutiche solide per uso vaginale
DE60142305D1 (de) Pharmazeutische zubereitung enthaltend n-ä2-(1,6,7,8-tetrahydro-2h-indenoä5,4 büfuran-8-yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllung
ATE193533T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
EA200200914A1 (ru) Система контроля дозирования для однократного ежедневного приема назначенного ципрофлоксацина
SE9403905D0 (sv) New formulations
ATE347886T1 (de) Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen
CA2356306A1 (en) Sulfated phosphatidylinositols, their preparation and use
ATE334658T1 (de) Arzneimittel zur verabreichung an schleimhäute
RU2219927C1 (ru) Анкардин-retard - средство пролонгированного антикальциевого действия
RU2002131189A (ru) Анкардин-retard-средство пролонгированного антикальциевого действия
AU3080692A (en) Slow-release medicament containing a dihydropyridine derivate as a nanosol and its preparation
TH27939B (th) สูตรส่วนผสมทางเภสัช